New Monoterpenoid Indole Alkaloids from Tabernaemontana crassa Inhibit β-Amyloid42 Production and Phospho-Tau (Thr217)
Li, S; Han, LL; Huang, KP; Ma, YH; Guo, LL; Guo, YR; Ran, XQ; Yao, YG; Hao, XJ; Luo, RC; Zhang, Y
2023
发表期刊INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷号24期号:2
摘要Eleven monoterpenoid indole alkaloids, including three new ones, tabercrassines A-C (1-3), were isolated from the seeds of Tabernaemontana crassa. Tabercrassine A (1) is an ibogan-ibogan-type bisindole alkaloid which is formed by the polymerization of two classic ibogan-type monomers through a C3 unit aliphatic chain. Their structures were established by extensive analysis of HRESIMS, NMR, and ECD spectra. Cellular assays showed that alkaloids 1-3 all reduce A beta 42 production and inhibit phospho-tau (Thr217), a new biomarker of Alzheimer's disease [AD] associated with BACE1-, NCSTN-, GSK3 beta-, and CDK5-mediated pathways, suggesting these alkaloids' potential against AD.
收录类别SCI
语种英语
文献类型期刊论文
条目标识符http://ir.kiz.ac.cn/handle/152453/14031
专题科研部门_疾病机理遗传学和进化医学学科组(姚永刚)
推荐引用方式
GB/T 7714
Li, S,Han, LL,Huang, KP,et al. New Monoterpenoid Indole Alkaloids from Tabernaemontana crassa Inhibit β-Amyloid42 Production and Phospho-Tau (Thr217)[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2023,24(2).
APA Li, S.,Han, LL.,Huang, KP.,Ma, YH.,Guo, LL.,...&Zhang, Y.(2023).New Monoterpenoid Indole Alkaloids from Tabernaemontana crassa Inhibit β-Amyloid42 Production and Phospho-Tau (Thr217).INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,24(2).
MLA Li, S,et al."New Monoterpenoid Indole Alkaloids from Tabernaemontana crassa Inhibit β-Amyloid42 Production and Phospho-Tau (Thr217)".INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24.2(2023).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
2024061110.pdf(5266KB)期刊论文出版稿开放获取CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, S]的文章
[Han, LL]的文章
[Huang, KP]的文章
百度学术
百度学术中相似的文章
[Li, S]的文章
[Han, LL]的文章
[Huang, KP]的文章
必应学术
必应学术中相似的文章
[Li, S]的文章
[Han, LL]的文章
[Huang, KP]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。